Medicinal chemistry aspects sphingolipid metabolism

被引：22
|
作者：
Nussbaumer, Peter [1 ]
机构：
[1] Novartis Inst BioMed Res, A-1235 Vienna, Austria
来源：
CHEMMEDCHEM | 2008年 / 3卷 / 04期
关键词：
drug targets; enzymes; inhibitors; sphingolipids; tool compounds;
D O I：
10.1002/cmdc.200700252
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：543 / 551
页数：9
相关论文
共 50 条
  • [11] Kynurenines and PACAP in Migraine: Medicinal Chemistry and Pathogenetic Aspects
    Tajti, Janos
    Szok, Delia
    Nagy-Grocz, Gabor
    Tuka, Bernadett
    Petrovics-Balog, Anna
    Toldi, Jozsef
    Vecsei, Laszlo
    CURRENT MEDICINAL CHEMISTRY, 2017, 24 (13) : 1332 - 1349
  • [12] Nitrates and no release: contemporary aspects in biological and medicinal chemistry
    Thatcher, GRJ
    Nicolescu, AC
    Bennett, BM
    Toader, V
    FREE RADICAL BIOLOGY AND MEDICINE, 2004, 37 (08) : 1122 - 1143
  • [13] Medicinal chemistry approaches to avoid aldehyde oxidase metabolism
    Pryde, David C.
    Thien-Duc Tran
    Jones, Peter
    Duckworth, Jonathan
    Howard, Martin
    Gardner, Iain
    Hyland, Ruth
    Webster, Rob
    Wenham, Tracey
    Bagal, Sharan
    Omoto, Kiyoyuki
    Schneider, Richard P.
    Lin, Jian
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (08) : 2856 - 2860
  • [14] Sphingolipid metabolism diseases
    Kolter, Thomas
    Sandhoff, Konrad
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2006, 1758 (12): : 2057 - 2079
  • [15] Nuclear Sphingolipid Metabolism
    Lucki, Natasha C.
    Sewer, Marion B.
    ANNUAL REVIEW OF PHYSIOLOGY, VOL 74, 2012, 74 : 131 - 151
  • [16] HISTORICAL ASPECTS AND FUTURE-DEVELOPMENTS IN TEACHING MEDICINAL CHEMISTRY
    ALBERT, A
    CHIMICA & L INDUSTRIA, 1984, 66 (11): : 694 - 699
  • [17] Mitochondrial Disturbances, Tryptophan Metabolites and Neurodegeneration: Medicinal Chemistry Aspects
    Szalardy, L.
    Klivenyi, P.
    Zadori, D.
    Fueloep, F.
    Toldi, J.
    Vecsei, L.
    CURRENT MEDICINAL CHEMISTRY, 2012, 19 (13) : 1899 - 1920
  • [18] Bioinorganic and medicinal chemistry: aspects of gold(I)-protein complexes
    Bhabak, Krishna P.
    Bhuyan, Bhaskar J.
    Mugesh, Govindasamy
    DALTON TRANSACTIONS, 2011, 40 (10) : 2099 - 2111
  • [19] Bilirubin Chemistry and Metabolism; Harmful and Protective Aspects
    Vitek, Libor
    Ostrow, J. Donald
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (25) : 2869 - 2883
  • [20] The Brazilian Medicinal Chemistry from 1998 to 2008 in the Journal of Medicinal Chemistry, Bioorganic and Medicinal Chemistry, Bioorganic and Medicinal Chemistry Letters and European Journal of Medicinal Chemistry
    Bastos, Renato S.
    Silva, Barbara, V
    Pinto, Angelo C.
    REVISTA VIRTUAL DE QUIMICA, 2009, 1 (01) : 67 - 86
12345